Lupin gains tentative FDA approval for Empagliflozin, Linagliptin, Metformin Hydrochloride ER…
This product will be manufactured at Lupin’s Pithampur facility in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
empagliflozin
Zydus receives final approval from US FDA for Empagliflozin and Metformin Hydrochloride Tablets
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults…
Empagliflozin reduces hospitalisation risk for heart-failure and cardiovascular death by 21 per…
With approval, Empagliflozin would become the first and only clinically-proven therapy to improve outcomes for the full spectrum…
European Commission approves Jardiance to treat heart failure
This new indication is based on the EMPEROR-Reduced trial, which showed a significant 25 per cent reduction in the combined…
Lupin gets tentative USFDA nod for empagliflozin and metformin hydrochloride ER tablets
They are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus
SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData
Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…
Empagliflozin reduced risk of death and hospitalisation for heart failure by 25 per cent in adults
Results from the Phase III EMPEROR-Reduced trial were published in The New England Journal of Medicine
Empagliflozin meets primary endpoint in Phase III heart failure trial
It reduced the risk of cardiovascular death or hospitalisation for heart failure versus placebo on top of standards of care in…
Lupin receives US FDA’s tentative approval for Empagliflozin and Linagliptin Tablets
Empagliflozin and Linagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
Alembic Pharmaceuticals receives US FDA’s tentative approval for Empagliflozin and Metformin…
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Synjardy Tablets of…